ヨーロッパの医薬品産業プロファイルでは、市場シェア、市場規模(2017 〜 2022 年の値、および 2027 年までの予測)などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Pfizer Inc.
8.4. Johnson & Johnson
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Europe pharmaceuticals market value: $ billion, 2017-22
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: F. Hoffmann-La Roche Ltd: key facts
Table 5: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 6: F. Hoffmann-La Roche Ltd: Key Employees
Table 7: Novartis AG: key facts
Table 8: Novartis AG: Annual Financial Ratios
Table 9: Novartis AG: Key Employees
Table 10: Novartis AG: Key Employees Continued
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: Annual Financial Ratios
Table 13: Pfizer Inc.: Key Employees
Table 14: Pfizer Inc.: Key Employees Continued
Table 15: Johnson & Johnson: key facts
Table 16: Johnson & Johnson: Annual Financial Ratios
Table 17: Johnson & Johnson: Key Employees
Table 18: Johnson & Johnson: Key Employees Continued
Table 19: Europe size of population (million), 2018-22
Table 20: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Europe gdp (current prices, $ billion), 2018-22
Table 22: Europe inflation, 2018-22
Table 23: Europe consumer price index (absolute), 2018-22
Table 24: Europe exchange rate, 2018-22
List of Figures
Figure 1: Europe pharmaceuticals market value: $ billion, 2017-22
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2022